(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
CAS: 86639-62-5
Ref. 3D-LDA63962
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar |
Información del producto
- 9-Nitrocamptothecin (Rubitecan)
4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline (EHNQ) is a potent antitumor agent that inhibits the growth of solid tumours by inducing apoptosis. EHNQ induces apoptosis through a caspase dependent pathway and triggers DNA damage. This drug has been shown to have potent anti-tumor activity in both bone cancer and subcutaneous tumors in mice. This compound also showed an increased antitumor response when used in combination with other chemotherapy drugs such as mitomycin C and vincristine sulfate. EHNQ has been shown to cause histological changes in the liver of animals treated with higher doses, but no such effects were observed at lower doses.
Propiedades químicas
Consulta técnica sobre: 3D-LDA63962 (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.